PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 47 filers reported holding PROFOUND MED CORP in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,138 | -32.8% | 12,047 | -0.2% | 0.00% | – |
| Q2 2023 | $159,434 | -57.8% | 12,071 | -65.3% | 0.00% | – |
| Q4 2022 | $378,244 | +117.4% | 34,791 | +0.3% | 0.00% | – |
| Q3 2022 | $174,000 | -37.9% | 34,670 | +7.6% | 0.00% | – |
| Q2 2022 | $280,000 | -11.9% | 32,223 | -3.5% | 0.00% | – |
| Q1 2022 | $318,000 | -19.5% | 33,377 | +0.8% | 0.00% | – |
| Q4 2021 | $395,000 | -12.4% | 33,124 | +14.1% | 0.00% | – |
| Q3 2021 | $451,000 | -63.0% | 29,028 | -57.4% | 0.00% | -100.0% |
| Q2 2021 | $1,218,000 | -9.3% | 68,172 | +0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,343,000 | -24.1% | 68,162 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $1,769,000 | +72.8% | 70,791 | +15.6% | 0.00% | 0.0% |
| Q3 2020 | $1,024,000 | +190.9% | 61,264 | +210.2% | 0.00% | – |
| Q2 2020 | $352,000 | +75.1% | 19,747 | -4.8% | 0.00% | – |
| Q1 2020 | $201,000 | +67.5% | 20,750 | +88.7% | 0.00% | – |
| Q4 2019 | $120,000 | – | 10,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
| Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
| GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
| Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
| AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
| PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
| Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
| Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |